Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Registry facet

Defined terms in the registry

195 documents of type defined term.

Documents

195 documents · page 1 of 5
  • CEI-GT-001Defined term2026-q3

    The Institute’s judgement of the extent to which an effect estimate is adequate to support a conclusion. Reported at one of four levels: high, moderate, low or very low…

    30 Jul 2026
  • CEI-GT-002Defined term2026-q3

    The Institute is confident that the true effect lies close to the estimate. Further research is very unlikely to change confidence in the estimate. A high rating is not…

    30 Jul 2026
  • CEI-GT-003Defined term2026-q3

    The true effect is likely to be close to the estimate, but there is a real possibility that it is substantially different. Further research is likely to have an…

    30 Jul 2026
  • CEI-GT-004Defined term2026-q3

    Confidence in the effect estimate is limited and the true effect may be substantially different. The Institute states in each case whether the limitation arises from…

    30 Jul 2026
  • CEI-GT-005Defined term2026-q3

    The Institute has very little confidence in the effect estimate. In this document set a very low rating most often reflects an absence of controlled human evidence…

    30 Jul 2026
  • CEI-GT-006Defined term2026-q3

    A state in which no study adequate to answer a question has been identified. The Institute records an absence of evidence as distinct from evidence of absence: the first…

    30 Jul 2026
  • CEI-GT-007Defined term2026-q3

    A finding, from a study adequately powered to detect an effect of the size of interest, that no such effect was observed. A negative result from an adequately powered…

    30 Jul 2026
  • CEI-GT-008Defined term2026-q3

    The reduction of a certainty rating from its starting level because of a concern in one of five domains: risk of bias, inconsistency, indirectness, imprecision and…

    30 Jul 2026
  • CEI-GT-009Defined term2026-q3

    The increase of a certainty rating above its starting level, applicable in principle to observational evidence showing a large effect, a dose–response gradient or a…

    30 Jul 2026
  • CEI-GT-010Defined term2026-q3

    The extent to which features of a study’s design or conduct could produce an effect estimate that systematically departs from the truth. Assessed at the level of the…

    30 Jul 2026
  • CEI-GT-011Defined term2026-q3

    A mismatch between the population, intervention, comparator or outcome of the contributing studies and those of the question being answered. Also applied where an…

    30 Jul 2026
  • CEI-GT-012Defined term2026-q3

    A confidence interval wide enough that its ends would support different decisions, or an event count too small to constrain the estimate. Assessed against a decision…

    30 Jul 2026
  • CEI-GT-013Defined term2026-q3

    Unexplained variation in effect estimates across contributing studies, beyond what chance would produce. Consistency of direction with variation in magnitude is treated…

    30 Jul 2026
  • CEI-GT-014Defined term2026-q3

    The risk that the studies available to a review are not a representative sample of the studies conducted, most often because studies with unfavourable results were not…

    30 Jul 2026
  • CEI-GT-015Defined term2026-q3

    The reporting of a subset of measured outcomes chosen after the results were known. Detected by comparing the published report with the registered protocol, which the…

    30 Jul 2026
  • CEI-GT-016Defined term2026-q3

    A structured table presenting, for each pre-specified outcome, the number of contributing participants and studies, the absolute and relative effect, the certainty…

    30 Jul 2026
  • CEI-GT-017Defined term2026-q3

    A document answering a structured question by identifying, appraising and combining the studies that bear on it, according to a protocol registered before the search was…

    30 Jul 2026
  • CEI-GT-018Defined term2026-q3

    A structured map of the evidence available for a question, published where the Institute judges that a quantitative synthesis is not yet supportable. A scoping review…

    30 Jul 2026
  • CEI-GT-019Defined term2026-q3

    A review whose unit of inclusion is a published systematic review rather than a primary study. Overlap between the included reviews is assessed and reported, because a…

    30 Jul 2026
  • CEI-GT-020Defined term2026-q3

    The four elements that define a review question: population, intervention, comparator and outcome. The Institute registers a PICO frame before searching and records any…

    30 Jul 2026
  • CEI-GT-021Defined term2026-q3

    The recording of a review question, eligibility criteria and analysis plan before the search is executed. Registration is what makes a subsequent change identifiable as…

    30 Jul 2026
  • CEI-GT-022Defined term2026-q3

    The record attached to every Institute synthesis listing each change made after protocol registration, when it was made, and why. A change that is not in the log did not…

    30 Jul 2026
  • CEI-GT-023Defined term2026-q3

    The assumption, required for indirect comparison, that participants in the contributing trials could in principle have been randomised to any of the compared…

    30 Jul 2026
  • CEI-GT-024Defined term2026-q3

    An estimate of the difference between two interventions that have not been compared directly, derived through their comparisons with a common comparator. Weaker than a…

    30 Jul 2026
  • CEI-GT-025Defined term2026-q3

    A synthesis combining direct and indirect comparisons across a connected set of interventions. The Institute publishes network estimates with its transitivity assessment…

    30 Jul 2026
  • CEI-GT-026Defined term2026-q3

    A repetition of an analysis under a different defensible assumption, conducted to establish whether a conclusion depends on that assumption. Reported whether or not the…

    30 Jul 2026
  • CEI-GT-027Defined term2026-q3

    An analysis restricted to a subset of participants. Hypothesis-generating unless the subgroup and the interaction test were pre-specified, and the Institute records…

    30 Jul 2026
  • CEI-GT-028Defined term2026-q3

    A formal test of whether a treatment effect differs across subgroups. A difference in statistical significance between two subgroups is not an interaction test and the…

    30 Jul 2026
  • CEI-GT-029Defined term2026-q3

    A result in which the observed effect does not differ from the comparator by more than chance would produce. Informative where the study was adequately powered for the…

    30 Jul 2026
  • CEI-GT-030Defined term2026-q3

    The treatment against which the intervention is compared. An effect estimate is always an estimate against a specific comparator, and no estimate is transferable to a…

    30 Jul 2026
  • CEI-GT-031Defined term2026-q3

    The effect of an intervention under the conditions of a controlled trial, in a selected population with protocol-driven adherence and follow-up.

    30 Jul 2026
  • CEI-GT-032Defined term2026-q3

    The effect of an intervention under ordinary conditions of use. Generally smaller than efficacy, principally because adherence and persistence outside a trial are lower.

    30 Jul 2026
  • CEI-GT-033Defined term2026-q3

    The allocation of participants to study arms by a chance process, which distributes both known and unknown prognostic factors between arms in expectation. The single…

    30 Jul 2026
  • CEI-GT-034Defined term2026-q3

    The prevention of foreknowledge of the next allocation by the person enrolling a participant. Distinct from blinding, which concerns knowledge after allocation, and…

    30 Jul 2026
  • CEI-GT-035Defined term2026-q3

    The withholding of knowledge of assignment from participants, investigators, outcome assessors or analysts. The Institute records who was blinded rather than describing…

    30 Jul 2026
  • CEI-GT-036Defined term2026-q3

    A design in which assignment is known to participants and investigators. Objective endpoint measurement limits but does not eliminate the resulting risk, because…

    30 Jul 2026
  • CEI-GT-037Defined term2026-q3

    A design in which neither participants nor investigators know the assignment. The Institute records the specific parties blinded, because the term is used inconsistently…

    30 Jul 2026
  • CEI-GT-038Defined term2026-q3

    A design in which the comparator is an inert preparation matched to the intervention in appearance and administration. Matching is imperfect where the intervention…

    30 Jul 2026
  • CEI-GT-039Defined term2026-q3

    A design in which the comparator is another active treatment. Establishes a difference between the two treatments and not an effect against no treatment.

    30 Jul 2026
  • CEI-GT-040Defined term2026-q3

    A design testing whether a treatment is not worse than a comparator by more than a pre-specified margin. A non-inferiority result does not establish superiority over…

    30 Jul 2026

page 1 of 5

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.